In this episode of Tuning Into the C-Suite, listeners are tuning into our next feature of the Meet the Board series where MHE's Senior Editor, Peter Wehrwein, and Associate Editor, Briana Contreras, speak with Managed Healthcare Executive Editorial Advisory Board Member, Don Hall, who is principal of DeltaSigma LLC. DeltaSigma is a consulting practice specializing in strategic problem solving for managed care organizations. In addition to being a loyal member of our board since 2007, Don most recently served as president and CEO of a nonprofit, provider-sponsored health plan. In this conversation, you’ll learn a bit about Don, personally, such as what he's currently reading, and his thoughts about the current issues healthcare is facing today.
Don Hall
Medicare Patients with PAH Face High Out-of-Pocket Costs | 2024 ATS
May 19th 2024Medicare patients who have pulmonary arterial hypertension and who are eligible for the low-income subsidy often have advanced disease, require prolonged disability insurance and face financial hardships, according to a poster at the annual ATS meeting.
Read More
FDA Updates for Week of May 13: First Bispecific Antibody for Solid Tumor
May 18th 2024The FDA has approved a new type of bispecific antibody to treat small cell lung cancer and an additional indication for Breyanzi for patients with follicular lymphoma. The agency has set review date for gene therapy for enzyme deficiency. In addition, Biogen have Eisai hve begun a rolling submission of subcutaneous Leqembi for Alzheimer’s disease.
Read More
Dr. Glaucomflecken the Opening Speaker Today at the 2024 ATS Meeting | 2024 ATS
May 18th 2024William Flanary, M.D.., has a huge social media following as Dr. Glaucomflecken, a character he created on Twitter when he was an ophthalmology resident in Iowa. More than 13,400 people have registered to attend the American Thoracic Society (ATS) International Conference, which is being held this weekend at the San Diego Convention Center.
Read More